Ursodeoxycholic acid in the treatment of pregnancy cholestasis: a data-set available for Meta-analyses

Abstract

Background

The recent literature on intrahepatic cholestasis of pregnancy raises questions on the best management of such a disease. Improved evidence might be achieved by meta-analyses.

Aim

Providing data for allowing individual patients meta-analyses and aggregate data meta-analyses.

Methods

Data were collected retrospectively at the Fabia Mater Hospital of Rome (Italy), between 2013 and 2018. Several variables were collected and analyzed according to low-level bile acid (less than 40 μmol/L) and high-level bile acid (at least 40 μmol/L). Eighty-three cases of pregnancy cholestasis, diagnosed according to itching symptoms and excluding bile diseases, were collected and analyzed, both descriptively and inferentially.

Conclusion

The analyzed data do not provide significant evidence supporting the use of ursodeoxycholic acid to prevent composite adverse fetal outcomes but they can be included in further meta-analyses.

Keywords:

• Intrahepatic cholestasis
• pregnancy
• data set
• outcome
• meta-analysis
• therapy

Disclosure statement

No potential conflict of interest was reported by the author(s).